Filing Details
- Accession Number:
- 0001567619-21-014512
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-05 17:01:38
- Reporting Period:
- 2021-08-03
- Accepted Time:
- 2021-08-05 17:01:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1740689 | Michael Lane | C/O Idexx Laboratories, Inc. One Idexx Drive Westbrook ME 04092 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-03 | 1,472 | $67.85 | 5,119 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-08-03 | 1,091 | $67.85 | 6,210 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-08-03 | 4,436 | $141.60 | 10,646 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-03 | 2,451 | $690.20 | 8,195 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-03 | 250 | $691.54 | 7,945 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-03 | 363 | $692.85 | 7,582 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-03 | 1,447 | $693.73 | 6,135 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-03 | 916 | $694.79 | 5,219 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-03 | 100 | $695.50 | 5,119 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-03 | 95 | $687.47 | 5,024 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-03 | 245 | $688.54 | 4,779 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-03 | 245 | $689.43 | 4,534 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-03 | 30 | $690.33 | 4,504 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-03 | 100 | $691.35 | 4,404 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-03 | 60 | $692.65 | 4,344 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-03 | 84 | $687.59 | 4,280 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-03 | 299 | $688.51 | 3,961 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-03 | 153 | $689.51 | 3,808 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-03 | 100 | $691.19 | 3,708 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-03 | 60 | $692.56 | 3,648 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-03 | 1 | $693.17 | 3,647 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right-to-buy) | Disposition | 2021-08-03 | 1,472 | $0.00 | 1,472 | $67.85 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2021-08-03 | 1,091 | $0.00 | 1,091 | $67.85 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2021-08-03 | 4,436 | $0.00 | 4,436 | $141.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 462 | 2026-02-13 | No | 4 | M | Direct | |
| 0 | 2026-02-13 | No | 4 | M | Direct | |
| 1,512 | 2027-02-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 592 | Indirect | by spouse |
Footnotes
- Includes a total of 23.2845 shares of common stock acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021.
- Represents the weighted average sales price of the shares sold ranging from a low of $690.00 to a high of $690.965 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $691.085 to a high of $692.08 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $692.33 to a high of $693.26 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $693.38 to a high of $694.38 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $694.49 to a high of $695.375 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $686.91 to a high of $687.90 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $688.07 to a high of $688.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $689.14 to a high of $690 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $690.17 to a high of $690.48 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $691.19 to a high of $691.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $692.27 to a high of $692.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $687.05 to a high of $687.83 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $688.09 to a high of $688.97 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $689.25 to a high of $690.18 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $690.45 to a high of $691.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $692.125 to a high of $692.85 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
- Grant of option to buy 2,072 shares of Issuer common stock that vested in five annual installments beginning February 14, 2017.
- Grant of option to buy 10,749 shares of Issuer common stock that vested in five annual installments beginning February 14, 2017.
- Grant of option to buy 10,386 shares of Issuer common stock that vest in five annual installments beginning February 14, 2018.
- Not applicable.
Billionaire Hedge Funds
